CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. Company Snapshot
Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. with three other companies in this sector in China: China Health Industries Holdings Incorporation (2016 sales of 50.42 million Chinese Renmimbi [US$7.65 million] ), Hainan Shuangcheng Pharmaceuticals Co Ltd (145.12 million Chinese Renmimbi [US$22.02 million] of which 87% was Self-made medicine Business), and Zhejiang Ausun Pharmaceutical Co Ltd (198.84 million Chinese Renmimbi [US$30.17 million] ).

Sales Analysis. Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. reported sales of 123.62 million Chinese Renmimbi (US$18.76 million) for the year ending December of 2016. This represents an increase of 30.8% versus 2015, when the company's sales were 94.53 million Chinese Renmimbi. Despite this increase, sales are still well below the level achieved in 2014, when Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. reported sales of 148.44 million Chinese Renmimbi. Sales of Health Products saw an increase that was more than double the company's growth rate: sales were up 133.9% in 2016, from 3.51 million Chinese Renmimbi to 8.21 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd.
  Stock Performance Chart for Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 29.19
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 9.6%  
4 Weeks n/a   52 Weeks n/a  
 
Hangzhou Tianmuhan Pharmaceutical Enterprise Co., Ltd. Key Data:
  Ticker: 600671 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 123,618,462
(Year Ending Jan 2017).
Employees: 531
  Currency: Chinese Renmimbi Market Cap: 3,554,725,653
  Fiscal Yr Ends: December Shares Outstanding: 121,778,885
  Share Type: A Gu Closely Held Shares: 67,104,048
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.